Oral vaccine consisting of eight synthetic copies of an HIV viral envelope protein borne on an inert backbone: Began another Phase I trial in 32 men and women v

United Biomedical Inc., Hauppauge, N.Y. Product: Oral vaccine consisting of eight synthetic copies of an HIV viral envelope protein borne on an inert backbone, delivered with a controlled-release, mic...